Literature DB >> 19377322

Progressive licensing of drugs: music or noise?

Joel Lexchin.   

Abstract

Year:  2008        PMID: 19377322      PMCID: PMC2645165     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


× No keyword cloud information.
  4 in total

Review 1.  Randomized trials stopped early for benefit: a systematic review.

Authors:  Victor M Montori; P J Devereaux; Neill K J Adhikari; Karen E A Burns; Christoph H Eggert; Matthias Briel; Christina Lacchetti; Teresa W Leung; Elizabeth Darling; Dianne M Bryant; Heiner C Bucher; Holger J Schünemann; Maureen O Meade; Deborah J Cook; Patricia J Erwin; Amit Sood; Richa Sood; Benjamin Lo; Carly A Thompson; Qi Zhou; Edward Mills; Gordon H Guyatt
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

2.  A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy.

Authors:  John Abraham; Courtney Davis
Journal:  Soc Sci Med       Date:  2005-03-02       Impact factor: 4.634

Review 3.  Pharmaceutical company funding and its consequences: a qualitative systematic review.

Authors:  Sergio Sismondo
Journal:  Contemp Clin Trials       Date:  2007-08-16       Impact factor: 2.226

4.  Notice of compliance with conditions: a policy in limbo.

Authors:  Joel Lexchin
Journal:  Healthc Policy       Date:  2007-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.